On the other hand, ICA-CUR could inhibit the gut microbiota-SCFAs, and SCFAs could regulate IGFBP2 levels, thus affecting the EGFR/STAT3/PD-L1 pathway and the differentiation of immune T cells, ultimately inhibiting PCa development. The gene discussed is STAT3; the disease is posterior cortical atrophy.